New approach for Autism and Parkinson with a novel phycobiotic (clinically tested probiotic with psychotropic effects).

Probioaspis is a unique dietary supplement for dopamine linked diseases. More specific, Probioaspis is a probiotic supplement for Parkinsons Disease and Autism Spectrum Disorder (ASD).

It is a unique supplement with high concentration of the specific strain of Lactobacillus plantarum and specific prebiotics enhancing the symbiotic property.

Probioaspis shows psychotropic properties and has great potential for improving stress-related symptoms and the dopamine and serotonin in key brain areas. As proven in lab research and scientific publication, daily consumption of high concentration of this specific probiotic increases the level of dopamine and serotonin in key brain areas like frontal cortex or hippocampus.

In addition, it has been completed the human clinical trial of  Probioaspis in 72 children with Autism spectrum Disorder (ASD). The study is under publication and the results of the study are outstanding. More specific it shows that

Probioaspis improved statistically significant, specific autism symptoms associated with communication and responsiveness.

In conclusion, it is ongoing another human clinical study on patients with Parkinson disease. The recruitment has been completed and the study is going to be completed at the end of 2018.

Commercial rights & brand holder: Aniva International S.A.